RESUMEN
Amid growing numbers of doctoral graduates entering an increasingly competitive global academic job market, concerns about equity in the hiring process and the value of the Canadian Ph.D. are mounting. Grounded within the historical context of the Canadianization Movement, we examine the doctoral credentials of 4,934 U15 social science faculty between 1977 and 2017 to understand the ebb and flow of incoming and outgoing faculty across the country's academic field. Our trend analyses reveal an overall increase in the proportion of Canadian-trained faculty hires with the noted exceptions of Canada's top three universities who display a strong presence of high-status American-trained faculty throughout. Results from the contemporary period, between 1997 and 2017, reveal a time of retirement during which outgoing Canadian-trained faculty are replaced with increasing proportions of American-trained academics.
RESUMEN
HIV-1 derived vectors are among the most efficient for gene transduction in mammalian tissues. As the parent virus, they carry out vector genome insertion into the host cell chromatin. Consequently, their preferential integration in transcribed genes raises several conceptual and safety issues. To address part of these questions, HIV-derived vectors have been engineered to be nonintegrating. This was mainly achieved by mutating HIV-1 integrase at functional hotspots of the enzyme enabling the development of streamlined nuclear DNA circles functional for transgene expression. Few integrase mutant vectors have been successfully tested so far for gene transfer. They are cleared with time in mitotic cells, but stable within nondividing retina cells or neurons. Here, we compared six HIV vectors carrying different integrases, either wild type or with different mutations (D64V, D167H, Q168A, K186Q+Q214L+Q216L, and RRK262-264AAH) shown to modify integrase enzymatic activity, oligomerization, or interaction with key cellular cofactor of HIV DNA integration as LEDGF/p75 or TNPO3. We show that these mutations differently affect the transduction efficiency as well as rates and patterns of integration of HIV-derived vectors suggesting their different processing in the nucleus. Surprisingly and most interestingly, we report that an integrase carrying the D167H substitution improves vector transduction efficiency and integration in both HEK-293T and primary CD34+ cells.
RESUMEN
The experimental autoimmune encephalitis (EAE) model is used for preclinical research into the pathogenesis of multiple sclerosis (MS), mostly in inbred, specific pathogen free (SPF)-raised laboratory mice. However, the naive state of the laboratory mouse immune system is considered a major hurdle in the translation of principles from the EAE model to the MS patient. Non-human primates (NHP) have an immune system harboring T- and B-cell memory against environmental antigens, similar as in humans. We sought to further refine existing NHP EAE models, which may help to bridge the gab between mouse EAE models and MS. We report here on new EAE models in three NHP species: rhesus monkeys (Macaca mulatta), cynomolgus monkeys (Macaca fascicularis) and common marmosets (Callithrix jacchus). EAE was induced with recombinant human myelin oligodendrocyte glycoprotein extracellular domain (1-125) (rhMOG) formulated in incomplete Freund's adjuvant (IFA). IFA lacks the bacterial antigens that are present in complete Freund's adjuvant (CFA), which are notorious for the induction of discomforting side effects. Clinically evident EAE could be induced in two out of five rhesus monkeys, six out of six cynomolgus monkeys and six out of six common marmosets. In each of these species, the presence of an early, high anti-rhMOG IgM response is correlated with EAE with an earlier onset and more severe disease course. Animals without an early high IgM response either did not develop disease (rhesus monkeys) or developed only mild signs of neurological deficit (marmoset and cynomolgus monkeys).
Asunto(s)
Encefalomielitis Autoinmune Experimental/inmunología , Adyuvante de Freund/inmunología , Glicoproteína Mielina-Oligodendrócito/inmunología , Adyuvantes Inmunológicos/farmacología , Animales , Encéfalo/patología , Callithrix , Encefalomielitis Autoinmune Experimental/patología , Adyuvante de Freund/farmacología , Humanos , Inmunoglobulina M/inmunología , Inmunohistoquímica , Macaca fascicularis , Macaca mulatta , Proteínas Recombinantes/inmunología , Médula Espinal/patologíaRESUMEN
Schwann cell (SC) transplantation is currently being discussed as a strategy that may promote functional recovery in patients with multiple sclerosis (MS) and other inflammatory demyelinating diseases of the central nervous system (CNS). However this assumes they will not only survive but also remyelinate demyelinated axons in the chronically inflamed CNS. To address this question we investigated the fate of transplanted SCs in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in the Dark Agouti rat; an animal model that reproduces the complex inflammatory demyelinating immunopathology of MS. We now report that SCs expressing green fluorescent protein (GFP-SCs) allografted after disease onset not only survive but also migrate to remyelinate lesions in the inflamed CNS. GFP-SCs were detected more frequently in the parenchyma after direct injection into the spinal cord, than via intra-thecal delivery into the cerebrospinal fluid. In both cases the transplanted cells intermingled with astrocytes in demyelinated lesions, aligned with axons and by twenty one days post transplantation had formed Pzero protein immunoreactive internodes. Strikingly, GFP-SCs transplantation was associated with marked decrease in clinical disease severity in terms of mortality; all GFP-SCs transplanted animals survived whilst 80% of controls died within 40 days of disease.
Asunto(s)
Movimiento Celular , Encefalomielitis Autoinmune Experimental/fisiopatología , Encefalomielitis Autoinmune Experimental/terapia , Vaina de Mielina/metabolismo , Recuperación de la Función , Células de Schwann/citología , Células de Schwann/trasplante , Animales , Astrocitos/metabolismo , Astrocitos/patología , Supervivencia Celular , Femenino , Proteínas Fluorescentes Verdes/metabolismo , Inyecciones Espinales , Vaina de Mielina/patología , Glicoproteína Mielina-Oligodendrócito , Ratas , Médula Espinal/irrigación sanguínea , Médula Espinal/patología , Médula Espinal/fisiopatología , Transducción GenéticaRESUMEN
EC Directive 86/609, governing the protection of animals used for scientific purposes, is currently under review. The new text remains to be finalized but will likely include the following measures:--prior authorization will be required for all scientific projects,--authorization will include on an ethical evaluation,--the 3Rs doctrine will be formally integrated,--ethical committees will be officially recognized. Clear guidelines are also provided on the scope, methodology and compliance monitoring of the protocols. Better public communication and, in some cases, retrospective assessment will be required. Implementation in national legislation will lead to a better integration of ethical considerations in scientific projects. The new Directive will also help to harmonize practices between the public and private sectors, with integrated internal controls during the implementation of ethical protocols. The impact of these new rules on the competitiveness of European research is discussed.
Asunto(s)
Experimentación Animal/legislación & jurisprudencia , Derechos del Animal/legislación & jurisprudencia , Experimentación Animal/ética , Animales , Animales de Laboratorio , Europa (Continente) , Regulación Gubernamental , HumanosRESUMEN
Numerous evidences indicate that the phenotype of a neurodegenerative disease and its pathogenetic mechanism are only loosely linked. The phenotype is directly related to the topography of the lesions and is reproduced whatever the mechanism as soon as the same neurons are destroyed or deficient: the symptoms of Parkinson disease are mimicked by any destruction of the neurons of the substantia nigra, caused for instance by the toxin MPTP. This does not mean that idiopathic Parkinson disease is due to MPTP. In the same way, mouse lines such as Reeler, Weaver and Staggerer in which ataxia occurs spontaneously does not help to understand human ataxias: now that mutations responsible for these phenotypes have been identified, it appears that one is responsible for lissencephaly (mutation of the reelin gene) and the other two have no equivalent in man. Therapeutic attempts, however, rely on the understanding of the pathogenetic mechanisms. Introducing a mutated human transgene in the genome of an animal has, in many instances, significantly improved this understanding. Transgenic mice have proven useful in reproducing lesions seen in neurodegenerative disease such as the plaques of Alzheimer disease (in the APP mouse which has integrated the mutated gene of the amyloid protein precursor), the tau glial and neuronal accumulation (seen in cases of frontotemporal dementias due to tau mutation), the nuclear inclusions caused by CAG triplet expansion (seen in the mutation of Huntington disease and autosomal dominant spinocerebellar ataxias). These recent advances have fostered numerous therapeutic attempts. Transgenesis in drosophila and in the worm Caenorhabditis elegans have opened new possibilities in the screening of protein partners, modifier genes, and potential therapeutic molecules. However, it is also becoming clear that introducing a human mutated gene in an animal does not necessarily trigger pathogenetic cascades identical to those seen in the human disease. Human diseases have to be studied in parallel with their animal models to ensure that the model mimic at least a few original mechanisms, on which new therapeutics may be tested.
Asunto(s)
Modelos Animales de Enfermedad , Enfermedades Neurodegenerativas , Enfermedad de Alzheimer/genética , Péptidos beta-Amiloides/deficiencia , Péptidos beta-Amiloides/genética , Péptidos beta-Amiloides/fisiología , Animales , Animales Modificados Genéticamente , Ataxia/genética , Caenorhabditis elegans/genética , Demencia/genética , Drosophila melanogaster/genética , Marcación de Gen , Genes Recesivos , Trastornos Heredodegenerativos del Sistema Nervioso/genética , Humanos , Enfermedad por Cuerpos de Lewy/metabolismo , Ratones , Ratones Noqueados , Ratones Mutantes Neurológicos , Repeticiones de Minisatélite , Enfermedades Neurodegenerativas/inducido químicamente , Neurotoxinas/toxicidad , Trastornos Parkinsonianos , Enfermedades por Prión/genética , Proteína Reelina , Especificidad de la Especie , alfa-Sinucleína/genética , alfa-Sinucleína/metabolismo , Proteínas tau/deficiencia , Proteínas tau/genética , Proteínas tau/fisiologíaRESUMEN
Myelin/oligodendrocyte glycoprotein (MOG) is a minor integral membrane protein specific to CNS myelin, encoded by a gene located in the major histocompatibility complex. MOG is an highly encephalitogenic autoantigen and a target for autoaggressive immune responses in CNS inflammatory demyelinating diseases. We performed transcriptomic analyses for a gene expressed only in mammalian CNS, myelin oligodendrocyte glycoprotein (MOG). Complex splicing patterns were exclusively found in primates and not in mice, unlike patterns found for other myelin protein genes. In addition to those shared with rodents, these multiple MOG isoforms likely support functions unique to the primate order, in particular maintenance of myelin structure, intracellular signaling, and modulation of CNS autoimmunity via exposure of specific MOG determinants. Developmentally, in human brain the splice variants of MOG appear at a late stage compared to the major isoform, coincidental with myelination and myelin maturation, unlike other myelin proteins. These findings are discussed within the framework of a biological basis for phenotype diversity in recent mammalian evolution and for the notoriously variable clinical expression of diseases such as multiple sclerosis.
Asunto(s)
Empalme Alternativo , Glicoproteína Asociada a Mielina/genética , Primates/genética , Secuencia de Aminoácidos , Animales , Callithrix , Bovinos , Sistema Nervioso Central/embriología , Preescolar , Feto/metabolismo , Humanos , Lactante , Macaca fascicularis , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Proteínas de la Mielina , Glicoproteína Asociada a Mielina/metabolismo , Glicoproteína Mielina-Oligodendrócito , ARN Mensajero/genéticaRESUMEN
The mechanisms limiting myelin repair in human central nervous system (CNS) remain unknown. Models of induced-demyelination in the nonhuman primate CNS may provide the necessary grounds to unravel these mechanisms and to investigate the development of strategies to promote myelin repair. To address this issue, we developed a model of focal demyelination in the adult Macaca fascicularis CNS. Lesions were induced by microinjection of lysolecithin in the optic nerve and the profile of remyelination was compared to that of lysolecithin-induced lesions of the spinal cord. In both structures, the time-course of demyelination as well as the onset of remyelination were found to be similar to that in the rodent CNS. While spinal cord lesions were remyelinated within 6 weeks, optic nerve lesions remained demyelinated for up to 3 months post-injection. The failure of remyelination in the optic nerve correlated with a reduced density of NG2+ oligodendrocyte progenitor cells, the presence of oligodendrocytes that fail to ensheath naked axons in the lesion and the absence of astrocyte recruitment in the lesion compared with spinal cord lesions. Our present data suggest that the reduced oligodendrocyte progenitor population, the improper activation of oligodendrocytes at the onset of remyelination in the optic nerve, and possibly, the involvement of astrocytes contribute to the chronicity of the optic nerve lesion. This model of chronic demyelination in the macaque optic nerve stresses its pertinence to unraveling the mechanisms limiting remyelination in multiple sclerosis.
Asunto(s)
Enfermedades Desmielinizantes/patología , Vaina de Mielina/patología , Regeneración Nerviosa/fisiología , Enfermedades del Nervio Óptico/patología , Animales , Astrocitos/citología , Enfermedades Desmielinizantes/inducido químicamente , Modelos Animales de Enfermedad , Femenino , Inmunohistoquímica , Lisofosfatidilcolinas/toxicidad , Macaca fascicularis , Microscopía Electrónica de Transmisión , Esclerosis Múltiple/patología , Vaina de Mielina/ultraestructura , Oligodendroglía/citología , Oligodendroglía/ultraestructura , Enfermedades del Nervio Óptico/inducido químicamente , Enfermedades de la Médula Espinal/inducido químicamente , Enfermedades de la Médula Espinal/patología , Células Madre/citologíaRESUMEN
Adult macaque Schwann cells were infected using adeno-associated virus type-2-derived vectors expressing the green fluorescent protein reporter gene under the control of the cytomegalovirus, the hybrid cytomegalovirus-betaactin, the myelin basic protein or the tetracycline-inducible promoters. On the basis of green fluorescent protein expression, gene transfer efficiency was compared in resting and dividing conditions following or not following hydroxyurea or etoposide treatment. Hydroxyurea allowed promoter-dependent expression of green fluorescent protein in infected Schwann cells. Etoposide treatment led to a high percentage of green fluorescent protein expressing cells (over 50%) with all promoters tested. When infected cells were grafted into demyelinated nude mice spinal cord, green fluorescent protein expression was only observed with the cytomegalovirus-betaactin and tetracycline-inducible promoters. In addition, adeno-associated virus type-2 infection reduced the grafted cell survival but increased their differentiation.
Asunto(s)
Dependovirus/fisiología , Regulación de la Expresión Génica/fisiología , Células de Schwann/virología , Transducción Genética , Análisis de Varianza , Animales , Recuento de Células/métodos , Proliferación Celular/efectos de los fármacos , Trasplante de Células/métodos , Células Cultivadas , Citomegalovirus/fisiología , Enfermedades Desmielinizantes/inducido químicamente , Enfermedades Desmielinizantes/cirugía , Etopósido/farmacología , Fibroblastos/metabolismo , Fibroblastos/virología , Regulación de la Expresión Génica/efectos de los fármacos , Vectores Genéticos/fisiología , Proteínas Fluorescentes Verdes/metabolismo , Hidroxiurea/farmacología , Inmunohistoquímica/métodos , Macaca fascicularis , Ratones , Proteína Básica de Mielina/metabolismo , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , Regiones Promotoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/fisiología , Células de Schwann/metabolismo , Factores de TiempoRESUMEN
Experimental studies provided overwhelming proof that transplants of myelin-forming cells achieve efficient remyelination in the CNS. Among cellular candidates, Schwann cells can be used for autologous transplantation to ensure robust remyelination of lesions and to deliver therapeutic factors in the CNS. In the present study, macaque Schwann cells expressing green fluorescent protein (GFP) were infected with human immunodeficiency virus-derived vectors overexpressing brain-derived neurotrophic factor (BDNF) or Neurotrophin 3 (NT-3), two neurotrophins that also modulate glial cell biology. The ability of transgenic Schwann cells to secrete growth factors was assessed by ELISA and showed 35- and 62-fold increases in BDNF and NT-3, respectively, in transduced macaque Schwann cell supernatants. Conditioned media of BDNF- and NT-3-transduced Schwann cells reduced Schwann cell proliferation and favored their differentiation in vitro. Transgenic cells were grafted in demyelinated spinal cords of adult nude mice. Two behavioral assays showed that NT-3- and BDNF-transduced Schwann cells promoted faster and stronger functional recovery than GFP-transduced Schwann cells. Morphological analysis indicated that functional recovery correlated with enhanced proliferation and differentiation of resident oligodendrocyte progenitors and enhanced oligodendrocyte and Schwann cell differentiation. Moreover, NT-3-transduced Schwann cells provided neuroprotection and reduced astrogliosis. These results underline the potential therapeutic benefit of combining neuroprotection and activation of myelin-forming cells to restore altered functions in demyelinating diseases of the CNS.
Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/metabolismo , Enfermedades Desmielinizantes/metabolismo , Neurotrofina 3/metabolismo , Recuperación de la Función/fisiología , Células de Schwann/trasplante , Médula Espinal/metabolismo , Animales , Factor Neurotrófico Derivado del Encéfalo/genética , Trasplante de Células/métodos , Células Cultivadas , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/patología , Enfermedades Desmielinizantes/cirugía , Femenino , Humanos , Macaca fascicularis , Masculino , Ratones , Ratones Desnudos , Fibras Nerviosas Mielínicas/metabolismo , Fibras Nerviosas Mielínicas/patología , Neurotrofina 3/genética , Células de Schwann/metabolismo , Médula Espinal/patología , Médula Espinal/trasplante , Transducción Genética/métodos , TrasplantesRESUMEN
Experimental transplantation in rodent models of CNS demyelination has led to the idea that Schwann cells may be candidates for cell therapy in human myelin diseases. Here we investigated the ability of Schwann cells autografts to generate myelin in the demyelinated monkey spinal cord. We report that monkey Schwann cells derived from adult peripheral nerve biopsies retain, after growth factor expansion and transduction with a lentiviral vector encoding green fluorescent protein, the ability to differentiate in vitro into promyelinating cells. When transplanted in the demyelinated nude mouse spinal cord, they promoted functional and anatomical repair of the lesions (n = 12). Furthermore, we obtained evidence by immunohistochemistry (n = 2) and electron microscopy (n = 4) that autologous transplantation of expanded monkey Schwann cells in acute lesions of the monkey spinal cord results in the repair of large areas of demyelination; up to 55% of the axons were remyelinated by donor Schwann cells, the remaining ones being remyelinated by oligodendrocytes. Autologous grafts of Schwann cells may thus be of therapeutic value for myelin repair in the adult CNS.
Asunto(s)
Enfermedades Desmielinizantes/terapia , Vaina de Mielina/fisiología , Regeneración Nerviosa , Células de Schwann/trasplante , Enfermedades de la Médula Espinal/terapia , Animales , Diferenciación Celular , División Celular , Células Cultivadas , Enfermedades Desmielinizantes/patología , Modelos Animales de Enfermedad , Femenino , Vectores Genéticos , VIH/genética , Macaca fascicularis , Masculino , Ratones , Ratones Desnudos , Vaina de Mielina/ultraestructura , Células de Schwann/virología , Médula Espinal/ultraestructura , Enfermedades de la Médula Espinal/patología , Transducción GenéticaRESUMEN
The myelin oligodendrocyte glycoprotein (MOG) is a minor CNS myelin-specific protein that is an important candidate autoantigen in multiple sclerosis. We now report that MOG mRNA transcripts are present in the peripheral nervous system of rodents and primates at levels approximately ten-fold lower than in brain as demonstrated by real time PCR. A major source of this signal are Schwann cells which are also shown to express MOG protein within their cytoplasm in vitro by immunohistochemistry. Expression of MOG by Schwann cells associated with tissue innervation may account for the widespread distribution of low levels of MOG mRNA transcripts, and potentially may provide a source of antigen that can influence the composition and function of the MOG-specific immune repertoire.
Asunto(s)
Glicoproteína Asociada a Mielina/biosíntesis , Sistema Nervioso Periférico/metabolismo , ARN Mensajero/análisis , Animales , Encéfalo/metabolismo , Células Cultivadas , Humanos , Inmunohistoquímica , Proteínas de la Mielina , Glicoproteína Asociada a Mielina/genética , Glicoproteína Mielina-Oligodendrócito , Tonsila Palatina/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células de Schwann/metabolismo , Timo/metabolismoRESUMEN
Transplantation of glial cells into the central nervous system (CNS) may be a promising approach for the treatment of myelin disorders such as multiple sclerosis (MS). Myelination by transplantation of oligodendrocyte precursors has been obtained in different animal models of demyelination. A strategy to favor CNS remyelination is to enrich the lesioned areas in growth factors to stimulate the quiescent population of oligodendrocyte precursors. In this context, we have developed a genetically modified CG4 cell line (CG4-FGF2), which are able to release significant amounts of fibroblast growth factor 2 (FGF2) in a controlable fashion in vitro. The data presented here demonstrate that upon induction with Dox, CG4-FGF2 cells retain their capacity to differentiate in vitro. Additionally, we provide evidence that FGF2 release by engineered cells enhance proliferation and migration of cells of the oligodendrocyte lineage without preventing them to differentiate and myelinate axons in vitro.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/biosíntesis , Vaina de Mielina/efectos de los fármacos , Neuronas/efectos de los fármacos , Oligodendroglía/citología , Oligodendroglía/metabolismo , Animales , Diferenciación Celular , División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Técnicas de Cocultivo , Ensayo de Inmunoadsorción Enzimática , Factor 2 de Crecimiento de Fibroblastos/genética , Humanos , Inmunohistoquímica , Ratas , Células Madre , Transfección , TransgenesRESUMEN
Precursor cells of the adult mouse subventricular zone (SVZ) are mobilized and recruited by a lysolecithin (LPC)-induced demyelination of the corpus callosum. Because age decreases the proliferation of the SVZ neural precursors as well as the potential for myelin repair of the adult central nervous system, we have compared the ability of young and aged adult neural precursors to respond to LPC-induced demyelination. With age, the SVZ cells lost their capacity to proliferate and to be recruited by the lesion. Whereas a single injection of fibroblast growth factor-2 or transforming growth factor-alpha stimulated the proliferation of SVZ and rostral migratory stream precursors in both groups of animals after demyelination, they favored recruitment at the lesion in young mice but not in aged ones. In vitro experiments using neurospheres derived from young and aged animals indicated that both populations have the same migratory performances. Our in vivo data thus suggest that aged neural precursors may loose their intrinsic capacities to respond to demyelination-induced signals. Alternatively, their function may be altered by modification of the aged extracellular environment.
Asunto(s)
Cuerpo Calloso/citología , Enfermedades Desmielinizantes/tratamiento farmacológico , Factor 2 de Crecimiento de Fibroblastos/farmacología , Células Madre/citología , Factor de Crecimiento Transformador alfa/farmacología , Factores de Edad , Animales , División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Enfermedades Desmielinizantes/inducido químicamente , Ventrículos Laterales/citología , Lisofosfatidilcolinas , Ratones , Ratones Endogámicos , Neuronas/citología , Células Madre/efectos de los fármacosRESUMEN
We assessed the developmental potential of human telencephalic progenitor cells, with and without previous amplification in vitro, following grafting into the nonlesioned adult mouse CNS. Cell suspensions, shown to contain neuroepithelium-like and neuroblast-like cells, were injected into the subventricular zone (SVZ) and the striatum. These two regions were selected for comparative studies because one, the SVZ, is mitotically active, whereas the other, the striatum, is mitotically inactive. In situ hybridization with a human-specific Alu probe showed that the cells survived for up to 30 weeks in both targets and migrated away from the injection site. Fresh cells continued to proliferate and gave rise to very extended grafts before differentiating into neurons and glia. We further show that, when grown in vitro prior to grafting, human cells acquired new properties: Their proliferation was very limited, and they differentiated more rapidly. This study therefore provides new information about the use of these cells, which are a potential tool for both cellular and gene therapy.
Asunto(s)
Trasplante de Tejido Encefálico/métodos , Diferenciación Celular/fisiología , División Celular/fisiología , Supervivencia de Injerto/fisiología , Neostriado/embriología , Proteínas del Tejido Nervioso , Trasplante de Células Madre , Telencéfalo/embriología , Telencéfalo/trasplante , Animales , Bromodesoxiuridina , Movimiento Celular/fisiología , Células Cultivadas , Femenino , Feto , Factor 2 de Crecimiento de Fibroblastos/farmacología , Humanos , Proteínas de Filamentos Intermediarios/metabolismo , Ventrículos Laterales/citología , Ventrículos Laterales/embriología , Ventrículos Laterales/cirugía , Ratones , Ratones Desnudos , Proteínas Asociadas a Microtúbulos/metabolismo , Neostriado/citología , Neostriado/cirugía , Nestina , Proteínas de Neurofilamentos/metabolismo , Neuroglía/citología , Neuroglía/metabolismo , Neuronas/citología , Neuronas/metabolismo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Células Madre/citología , Telencéfalo/citología , Tubulina (Proteína)/metabolismo , Vimentina/metabolismo , Proteínas tau/metabolismoRESUMEN
The capacity of multipotential progenitor cells of the adult mammalian forebrain to generate myelin-forming oligodendrocytes was tested by grafting fragments of different regions of the subventricular zone (SVZ) of the lateral ventricle and the striatum of 6-month-old wild-type mice into the brain of neonate shiverer and wild-type mice. Without growth factor treatment, only few cells of the rostral SVZ survived and formed myelin after engraftment. Treating donors prior to transplantation with a single intraperitoneal injection of epidermal growth factor, basic fibroblast growth factor 2 (FGF-2), and platelet-derived growth factor AB (PDGF(AB)) vigorously promoted the survival, migration, and differentiation of the grafted SVZ cells into myelin-forming oligodendrocytes. In situ, both growth factors expanded the constitutively proliferative PSA-NCAM+ population and favored their differentiation toward the neuronal and oligodendroglial cell fate. The adult central nervous system thus harbors a focal reservoir of FGF-2 and PDGF(AB)-responsive cells which are able to generate substantial amounts of myelin-forming oligodendrocytes in vivo, opening a new prospective area for therapy in demyelinating diseases.